Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study

BACKGROUND: After multiple lines of therapies, no guideline or consensus is currently available for the treatment of patients with metastatic breast cancer. This study aims to evaluate the efficacy of a novel re-subtyping and treatment strategy based on ctDNA alterations. METHODS: This observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhe-Yu, Tang, Yu, Liu, Liping, Xie, Ning, Tian, Can, Liu, Binliang, Zou, Lixin, Zhou, Wei, Wang, Yikai, Xia, Xuefeng, Ouyang, Quchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304912/
https://www.ncbi.nlm.nih.gov/pubmed/35875816
http://dx.doi.org/10.1016/j.eclinm.2022.101567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304912/
https://www.ncbi.nlm.nih.gov/pubmed/35875816
http://dx.doi.org/10.1016/j.eclinm.2022.101567

Ejemplares similares